The PerkinElmer® COVID-19 Antigen Test has been approved by the National Sanitary Surveillance Agency of Brazil (ANVISA) as a Class III in vitro diagnostic (IVD) device. This approval authorizes the sale, distribution, and use of PerkinElmer’s 15-minutes antigen test in Brazil for the qualitative detection of SARS-CoV-2, with nasal or nasopharyngeal swabs. The PerkinElmer® COVID-19 Antigen test is an accurate and efficient product to screen for the presence of COVID-19.
COVID Passports for the Airlines Industry | PerkinElmer participated in the recent CAPALive event, Herd immunity, vaccines and restarting local and global travel. Listen to Arvind Kothandaraman discuss how COVID-19 passports will help the airline industry recover by ensuring safe and secure travel.
Identifying the Delta VOC (B.1.617) with the NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit | On May 10, 2021, the World Health Organization (WHO) designated the delta variant a variant of concern (VOC), the fourth variant to receive this designation.
Watch our on-demand webinar | During the past year, laboratories across the globe have joined together to take up the fight against COVID19 by rapidly launching clinical diagnostic assays to detect affected individuals and ultimately help curb the spread of the disease.
Currently the CDC recommends that any fully vaccinated person who experiences symptoms consistent with COVID-19 be tested for SARS-CoV-2 if indicated. That leads to the question can COVID-19 vaccinations cause false positives? Here’s what we know.
Watch Our Webinar to Expand Your Single-Cell Opportunities | Biological resolution at the level of individual cells is powering the next phase of precision health. Honeycomb is developing a new paradigm in single-cell technology — integrating a sample storage solution within single-cell profiling.
Verifying the Presence of the SARS-CoV-2 in Positive RT-PCR Samples | The PerkinElmer® New Coronavirus Nucleic Acid Detection kit has been identified as having the highest sensitivity of the commercially available COVID-19 diagnostic kits. The purpose of this study is to use Next Generation Sequencing (NGS) of samples with a range of Ct values to verify the presence of the SARS-CoV-2 genome.